What is Predisurge?
Predisurge is a forward-thinking software company dedicated to advancing decision support solutions for cardiovascular physicians and the medical device sector. Their proprietary products, such as PlanOp iSizing and the Endoleak Risk Index, are engineered to elevate precision in aortic sizing and refine risk assessment for endovascular interventions. By leveraging AI-powered digital twin technology, Predisurge aims to significantly improve patient outcomes and streamline vascular care processes, collaborating with leading medical institutions to drive innovation.
How much funding has Predisurge raised?
Predisurge has raised a total of $6.8M across 1 funding round:
Series A
$6.8M
Series A (2023): $6.8M with participation from Liftt and The European Innovation Council
Key Investors in Predisurge
Liftt
Liftt is a Venture Capital holding company focused on deep tech technologies, employing a multi-vertical operational approach aimed at creating impact. Active in Europe with a global vision, Liftt acts as a catalyst and facilitator of innovation, connecting ideas, talent, territories, and financial resources.
The European Innovation Council
The European Innovation Council is a company that operates in the Colleges & Universities industry. It employs 20to49 people and has 1Mto5M of revenue.
What's next for Predisurge?
The recent major strategic investment positions Predisurge for accelerated growth and market penetration. This capital infusion is expected to fuel further development of their AI-driven decision support tools, enhance their market reach within the cardiovascular medical device industry, and potentially expand their digital twin capabilities to other complex medical fields. The company's focus on precision and patient outcomes suggests a strategic direction towards becoming a key player in the digital health transformation of vascular care.
See full Predisurge company page
